IMMUNOMEDICS, INC.: 10-K filed 2012-08-23

Name: IMMUNOMEDICS, INC.: 10-K filed 2012-08-23
Creator: IMMUNOMEDICS, INC.
License: https://creativecommons.org/licenses/by/4.0/

What IMMUNOMEDICS, INC. reported in its annual report filed 2012-08-23 (fiscal FY 2012): 38 published measures, 148 facts as tagged in accession 0001193125-12-366797.

This filing

Form: 10-K (annual report)
Filed: 2012-08-23
Fiscal period: fiscal FY 2012
Accession: 0001193125-12-366797 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All IMMUNOMEDICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit
At 2012-06-30	38,635,221	USD
At 2011-06-30	34,324,773	USD
At 2010-06-30	46,122,000	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2012-06-30	32,026,769	USD
At 2011-06-30	27,815,949	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2012-06-30	32,838,096	USD
At 2011-06-30	27,097,610	USD
At 2010-06-30	29,533,230	USD
At 2009-06-30	27,390,778	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	-7,517,000	USD	91
2011-07-01 to 2012-06-30	809,952	USD	366
2012-01-01 to 2012-03-31	-7,266,000	USD	91
2011-10-01 to 2011-12-31	20,694,000	USD	92
2011-07-01 to 2011-09-30	-5,101,000	USD	92
2011-04-01 to 2011-06-30	2,280,000	USD	91
2010-07-01 to 2011-06-30	-15,070,421	USD	365
2011-01-01 to 2011-03-31	-7,457,000	USD	90
2010-10-01 to 2010-12-31	-3,427,000	USD	92
2010-07-01 to 2010-09-30	-6,466,000	USD	92
2009-07-01 to 2010-06-30	36,996,226	USD	365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2011-07-01 to 2012-06-30	4,554,804	USD	366
2010-07-01 to 2011-06-30	-11,897,171	USD	365
2009-07-01 to 2010-06-30	-7,068,700	USD	365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2011-07-01 to 2012-06-30	568,133	USD	366
2010-07-01 to 2011-06-30	605,988	USD	365
2009-07-01 to 2010-06-30	684,464	USD	365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2011-07-01 to 2012-06-30	1,753,815	USD	366
2010-07-01 to 2011-06-30	243,529	USD	365
2009-07-01 to 2010-06-30	25,616	USD	365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2011-07-01 to 2012-06-30	-568,133	USD	366
2010-07-01 to 2011-06-30	9,218,022	USD	365
2009-07-01 to 2010-06-30	9,185,536	USD	365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2012-06-30	-217,088,442	USD
At 2011-06-30	-217,898,394	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	75,540,000	shares	91
2011-07-01 to 2012-06-30	75,481,007	shares	366
2012-01-01 to 2012-03-31	75,491,000	shares	91
2011-10-01 to 2011-12-31	75,458,000	shares	92
2011-07-01 to 2011-09-30	75,435,000	shares	92
2011-04-01 to 2011-06-30	75,378,000	shares	91
2010-07-01 to 2011-06-30	75,313,349	shares	365
2011-01-01 to 2011-03-31	75,318,000	shares	90
2010-10-01 to 2010-12-31	75,289,000	shares	92
2010-07-01 to 2010-09-30	75,269,000	shares	92
2009-07-01 to 2010-06-30	75,200,866	shares	365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	75,540,000	shares	91
2011-07-01 to 2012-06-30	76,174,377	shares	366
2012-01-01 to 2012-03-31	75,491,000	shares	91
2011-10-01 to 2011-12-31	75,964,000	shares	92
2011-07-01 to 2011-09-30	75,435,000	shares	92
2011-04-01 to 2011-06-30	76,190,000	shares	91
2010-07-01 to 2011-06-30	75,313,349	shares	365
2011-01-01 to 2011-03-31	75,318,000	shares	90
2010-10-01 to 2010-12-31	75,289,000	shares	92
2010-07-01 to 2010-09-30	75,269,000	shares	92
2009-07-01 to 2010-06-30	75,994,190	shares	365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	-0.1	USD/shares	91
2011-07-01 to 2012-06-30	0.01	USD/shares	366
2012-01-01 to 2012-03-31	-0.1	USD/shares	91
2011-10-01 to 2011-12-31	0.27	USD/shares	92
2011-07-01 to 2011-09-30	-0.06	USD/shares	92
2011-04-01 to 2011-06-30	0.03	USD/shares	91
2010-07-01 to 2011-06-30	-0.2	USD/shares	365
2011-01-01 to 2011-03-31	-0.1	USD/shares	90
2010-10-01 to 2010-12-31	-0.05	USD/shares	92
2010-07-01 to 2010-09-30	-0.08	USD/shares	92
2009-07-01 to 2010-06-30	0.49	USD/shares	365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	-0.1	USD/shares	91
2011-07-01 to 2012-06-30	0.01	USD/shares	366
2012-01-01 to 2012-03-31	-0.1	USD/shares	91
2011-10-01 to 2011-12-31	0.27	USD/shares	92
2011-07-01 to 2011-09-30	-0.06	USD/shares	92
2011-04-01 to 2011-06-30	0.03	USD/shares	91
2010-07-01 to 2011-06-30	-0.2	USD/shares	365
2011-01-01 to 2011-03-31	-0.1	USD/shares	90
2010-10-01 to 2010-12-31	-0.05	USD/shares	92
2010-07-01 to 2010-09-30	-0.08	USD/shares	92
2009-07-01 to 2010-06-30	0.49	USD/shares	365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2011-07-01 to 2012-06-30	209,785	USD	366
2010-07-01 to 2011-06-30	109,880	USD	365
2009-07-01 to 2010-06-30	-1,228,885	USD	365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit
At 2012-06-30	2,527,500	USD
At 2011-06-30	3,456,150	USD
At 2010-06-30	4,328,000	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2011-07-01 to 2012-06-30	1,961,561	USD	366
2010-07-01 to 2011-06-30	1,870,771	USD	365
2009-07-01 to 2010-06-30	1,808,860	USD	365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2011-07-01 to 2012-06-30	874,167	USD	366
2010-07-01 to 2011-06-30	-19,022,662	USD	365
2009-07-01 to 2010-06-30	33,933,131	USD	365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2012-06-30	35,479,433	USD
At 2011-06-30	30,257,618	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2012-06-30	5,594,800	USD
At 2011-06-30	5,548,318	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2012-06-30	659,958	USD
At 2011-06-30	736,980	USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2012-06-30	415,876	USD
At 2011-06-30	289,604	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	720,000	USD	91
2012-01-01 to 2012-03-31	677,000	USD	91
2011-10-01 to 2011-12-31	930,000	USD	92
2011-07-01 to 2011-09-30	764,000	USD	92
2011-04-01 to 2011-06-30	795,000	USD	91
2011-01-01 to 2011-03-31	751,000	USD	90
2010-10-01 to 2010-12-31	622,000	USD	92
2010-07-01 to 2010-09-30	1,021,000	USD	92

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2011-07-01 to 2012-06-30	24,824,024	USD	366
2010-07-01 to 2011-06-30	25,368,586	USD	365
2009-07-01 to 2010-06-30	19,853,880	USD	365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2012-06-30	75,597,066	shares
At 2011-06-30	75,463,066	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2012-06-30	248,737,450	USD
At 2011-06-30	245,023,414	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2012-06-30	80,161	USD
At 2011-06-30	394,669	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit
At 2012-06-30	31,739,209	USD
At 2011-06-30	27,641,963	USD
At 2010-06-30	40,718,615	USD
At 2009-06-30	1,976,541	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2012-06-30	28,235,000	USD
At 2011-06-30	27,667,000	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2012-06-30	25,707,000	USD
At 2011-06-30	24,211,000	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2012-06-30	30,000	USD
At 2011-06-30	30,000	USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2012-06-30	1,301,212	USD
At 2011-06-30	1,134,492	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2011-07-01 to 2012-06-30	696,378	USD	366
2010-07-01 to 2011-06-30	-15,244,407	USD	365
2009-07-01 to 2010-06-30	36,996,226	USD	365

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2011-07-01 to 2012-06-30	495,444	USD	366
2010-07-01 to 2011-06-30	-15,016,966	USD	365
2009-07-01 to 2010-06-30	36,907,598	USD	365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2011-07-01 to 2012-06-30	5,762,576	USD	366
2010-07-01 to 2011-06-30	7,116,055	USD	365
2009-07-01 to 2010-06-30	5,348,640	USD	365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2011-07-01 to 2012-06-30	1,496,783	USD	366
2010-07-01 to 2011-06-30	1,477,639	USD	365
2009-07-01 to 2010-06-30	1,436,017	USD	365

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2011-07-01 to 2012-06-30	23,144	USD	366
2010-07-01 to 2011-06-30	441,531	USD	365
2009-07-01 to 2010-06-30	658,609	USD	365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2011-07-01 to 2012-06-30	-54,225	USD	366
2010-07-01 to 2011-06-30	288,399	USD	365
2009-07-01 to 2010-06-30	-354,689	USD	365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2011-07-01 to 2012-06-30	126,272	USD	366
2010-07-01 to 2011-06-30	-245,105	USD	365
2009-07-01 to 2010-06-30	901,789	USD	365

Inspect the source

Entity: IMMUNOMEDICS, INC. / CIK 0000722830
Captured: 2026-09-22 19:30 UTC
SEC response SHA-256: d9e652f20067bb0e424f518a6160c3705c40f702f691a59fdf4f1d40e5e05b37

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000722830.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))